Literature DB >> 183749

Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice.

G M Kostner, P Laggner, H J Prexl, A Holasek.   

Abstract

The abnormal lipoproteins of the density range 1.019-1.063g/cm3 occurring in the plasma of patients with obstructive jaundice were studied. Subfractionation of this density class by combined sodium phosphotungstate precipitation, ultracentrifugation, and column chromatography on hydroxyapatite and agarose gel yielded essentially three fractions: (1) lipoprotein-X, (2) A triglyceride-rich lipoprotein for which we propose the term lipoprotein-Y and (3) an abnormal lipoprotein, lipoprotein-B. Marked differences between these fractions with respect to electron-microscopic appearance, hydrated densities, chemical composition and immunochemical characteristics were observed. The protein moiety of lipoprotein-X consisted primarily of apolipoprotein-C and albumin. Lipoprotein-Y showed, in addition to apolipoprotein-C, the presence of apolipoprotein-B. The 'lipoprotein-B' fraction isolated from sera of these patients had higher triglyceride and free cholesterol contents than that of normal individuals and an unusually high content of apolipoprotein-C. The relative distribution of lipoprotein-X, lipoprotein-Y and 'lipoprotein-B' varied from patient to patient. The importance of considering the existence of lipoprotein-Y in screening patients for cholestasis by the lipoprotein-X test is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183749      PMCID: PMC1163866          DOI: 10.1042/bj1570401

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:Cholesterol acyltransferase deficiency.

Authors:  Harald Torsvik; Kåre Berg; Harry N. Magnani; Walter J. McConathy; Peter Alaupovic; Egil Gjone
Journal:  FEBS Lett       Date:  1972-08-01       Impact factor: 4.124

Review 2.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

3.  Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation.

Authors:  G M Kostner; J R Patsch; S Sailer; H Braunsteiner; A Holasek
Journal:  Eur J Biochem       Date:  1974-06-15

4.  Significance of the LP-X test in differential diagnosis of jaundice.

Authors:  D Seidel; H Gretz; C Ruppert
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

5.  Characterization and quantitation of the apolipoproteins from human chyle chylomicrons.

Authors:  G Kostner; A Holasek
Journal:  Biochemistry       Date:  1972-03-28       Impact factor: 3.162

6.  Rate of in vitro incorporation of precursors into hepatic lipids and proteins in patients with extrahepatic cholestasis.

Authors:  H Stakeberg; H Lundborg; T Scherstén
Journal:  Eur J Clin Invest       Date:  1974-12-05       Impact factor: 4.686

7.  [Isolation and study of abnormal serum lipoproteins during retention jaundice after flocculation by polyvinylpyrrolidone].

Authors:  M Burstein; J Caroli
Journal:  Rev Fr Etud Clin Biol       Date:  1968-04

8.  Abnormal serum lipoprotein in cholestasis: identification and isolation.

Authors:  J Picard; D Veissiere
Journal:  Clin Chim Acta       Date:  1970-10       Impact factor: 3.786

9.  Isolation and characterization of lipoprotein B from high-density human serum lipoproteins.

Authors:  G Kostner
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

10.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins.

Authors:  K R Norum; J A Glomset; A V Nichols; T Forte
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

View more
  9 in total

1.  Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Authors:  Lita A Freeman; Robert D Shamburek; Maureen L Sampson; Edward B Neufeld; Masaki Sato; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Lipid Res       Date:  2019-02-26       Impact factor: 5.922

2.  LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Authors:  Boris L Vaisman; Edward B Neufeld; Lita A Freeman; Scott M Gordon; Maureen L Sampson; Milton Pryor; Emily Hillman; Milton J Axley; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2018-12-18       Impact factor: 4.030

Review 3.  Plasma lipids and lipoproteins in liver disease.

Authors:  N McIntyre
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

4.  Secretion of lipoprotein-X by perfused livers of rats with cholestasis.

Authors:  T E Felker; R L Hamilton; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

5.  The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.

Authors:  E Steyrer; S Durovic; S Frank; W Giessauf; A Burger; H Dieplinger; R Zechner; G M Kostner
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

6.  The interaction of human plasma low density lipoproteins with glycosamino-glycans: influence of the chemical composition.

Authors:  G M Kostner; R Zechner; M Bihari-Varga; E Gruber
Journal:  Lipids       Date:  1985-01       Impact factor: 1.880

7.  Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.

Authors:  Kunpeng Hu; Maria C Perez-Matos; Josepmaria Argemi; Eduardo Vilar-Gomez; Irina Shalaurova; Esther Bullitt; Lee Landeen; Go Sugahara; Huiyan Deng; Karan Mathur; Stephanie Tran; Huimei Cai; Hanchang He; Yusuf Yalcin; Joana Vieira Barbosa; Meritxell Ventura-Cots; Katherine Marx; Aniket P Gad; Sebastian Niezen; Sofia Izunza Barba; Lay-Hong Ang; Yury V Popov; Zachary Fricker; Michelle Lai; Michael Curry; Nezam Afdhal; Gyongyi Szabo; Kenneth J Mukamal; Arun J Sanyal; James D Otvos; Raza Malik; Takeshi Saito; Margery A Connelly; Naga P Chalasani; Ramon Bataller; Z Gordon Jiang
Journal:  Hepatology       Date:  2021-12-07       Impact factor: 17.298

8.  Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay.

Authors:  Shimpi Bedi; Erwin Garcia; Elias J Jeyarajah; Irina Shalaurova; Maria Camila Perez-Matos; Z Gordon Jiang; Robin P F Dullaart; Steven P Matyus; William J Kirk; James D Otvos; W Sean Davidson; Margery A Connelly
Journal:  J Clin Med       Date:  2020-09-10       Impact factor: 4.241

9.  Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein.

Authors:  Eline H van den Berg; Jose L Flores-Guerrero; Eke G Gruppen; Erwin Garcia; Margery A Connelly; Vincent E de Meijer; Stephan J L Bakker; Hans Blokzijl; Robin P F Dullaart
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.